Impact of lung transplantation on recipient quality of life: A serial, prospective, multicenter analysis through the first posttransplant year

Chest

Volumn 143, Issue 3, 2013, Pages 744-750

  Copeland, C Ashley Finlen ^a   Vock, David M ^c   Pieper, Karen ^b   Mark, Daniel B ^b   Palmer, Scott M ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VALGANCICLOVIR;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHYSICAL WELL BEING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SHORT FORM 36; SURGICAL TECHNIQUE; WELLBEING;

EID: 84874960889     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0971     Document Type: Article

References (36)

1. Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: twenty-eighth adult lung and heart-lung transplant report - 2011. J Heart Lung Transplant. 2011; 30 (10): 1104-1122.
2. Titman A, Rogers CA, Bonser RS, Banner NR, Sharples LD. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am J Transplant. 2009; 9 (7): 1640-1649.
3. Studer SM, Levy RD, McNeil K, Orens JB. Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J. 2004; 24 (4): 674-685.
4. Cohen L, Littlefield C, Kelly P, Maurer J, Abbey S. Predictors of quality of life and adjustment after lung transplantation. Chest. 1998; 113 (3): 633-644.
5. Goetzmann L, Sarac N, Ambühl P, et al. Psychological response and quality of life after transplantation: a comparison between heart, lung, liver and kidney recipients. Swiss Med Wkly. 2008; 138 (33-34): 477-483.
6. Smeritschnig B, Jaksch P, Kocher A, et al. Quality of life after lung transplantation: a cross-sectional study. J Heart Lung Transplant. 2005; 24 (4): 474-480.
7. Pinson CW, Feurer ID, Payne JL, Wise PE, Shockley S, Speroff T. Health-related quality of life after different types of solid organ transplantation. Ann Surg. 2000; 232 (4): 597- 607.
8. Vasiliadis H-M, Collet J-P, Poirier C. Health-related qualityof- life determinants in lung transplantation. J Heart Lung Transplant. 2006; 25 (2): 226-233.
9. Gross CR, Savik K, Bolman RM III, Hertz MI. Long-term health status and quality of life outcomes of lung transplant recipients. Chest. 1995; 108 (6): 1587-1593.
10. Busschbach JJ, Horikx PE, van den Bosch JM, Brutel de la Rivière A, de Charro FT. Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis. Chest. 1994; 105 (3): 911-917.
11. Kugler C, Fischer S, Gottlieb J, et al. Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplant. 2005; 24 (12): 2262-2268.
12. TenVergert EM, Essink-Bot M-L, Geertsma A, van Enckevort PJ, de Boer WJ, van der Bij W. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest. 1998; 113 (2): 358-364.
13. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. Assessment of quality of life in lung transplantation using a simple generic tool. Thorax. 2001; 56 (3): 218-222.
14. Stavem K, Bjørtuft O, Lund MB, Kongshaug K, Geiran O, Boe J. Health-related quality of life in lung transplant candidates and recipients. Respiration. 2000; 67 (2): 159-165.
15. Limbos MM, Joyce DP, Chan CKN, Kesten S. Psychological functioning and quality of life in lung transplant candidates and recipients. Chest. 2000; 118 (2): 408-416.
16. Rutherford RM, Fisher AJ, Hilton C, et al. Functional status and quality of life in patients surviving 10 years after lung transplantation. Am J Transplant. 2005; 5 (5): 1099-1104.
17. Myaskovsky L, Dew MA, McNulty ML, et al. Trajectories of change in quality of life in 12-month survivors of lung or heart transplant. Am J Transplant. 2006; 6 (8): 1939-1947.
18. Lanuza DM, Lefaiver C, Mc Cabe M, Farcas GA, Garrity E Jr. Prospective study of functional status and quality of life before and after lung transplantation. Chest. 2000; 118 (1): 115-122.
19. Gerbase MW, Spiliopoulos A, Rochat T, Archinard M, Nicod LP. Health-related quality of life following single or bilateral lung transplantation: a 7-year comparison to functional outcome. Chest. 2005; 128 (3): 1371-1378.
20. Rodrigue JR, Baz MA, Kanasky WF Jr, MacNaughton KL. Does lung transplantation improve health-related quality of life? The University of Florida experience. J Heart Lung Transplant. 2005; 24 (6): 755-763.
21. Santana M-J, Feeny D, Jackson K, Weinkauf J, Lien D. Improvement in health-related quality of life after lung transplantation. Can Respir J. 2009; 16 (5): 153-158.
22. Kugler C, Tegtbur U, Gottlieb J, et al. Health-related quality of life in long-term survivors after heart and lung transplantation: a prospective cohort study. Transplantation. 2010; 90 (4): 451- 457.
23. Palmer SM, Limaye AP, Banks M, et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med. 2010; 152 (12): 761-769.
24. Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol. 1998; 51 (11): 903-912.
25. Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response. Qual Life Res. 2001; 10 (5): 405-413.
26. Ware J, Kosinski M, Keller S. Sf-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA : The Health Institute; 1994.
27. Cohen J. Statistical Power for the Behavioral Sciences. 2nd ed. Hillsdale, NJ : Lawrence Erlbaum Associates, Inc.; 1988.
28. Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. New York, NY : Wiley; 2004.
29. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York, NY : Springer; 2009.
30. Cohen DJ, Van Hout B, Serruys PW, et al; Synergy between PCI with Taxus and Cardiac Surgery Investigators. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med. 2011; 364 (11): 1016-1026.
31. Gerbase MW, Soccal PM, Spiliopoulos A, Nicod LP, Rochat T. Long-term health-related quality of life and walking capacity of lung recipients with and without bronchiolitis obliterans syndrome. J Heart Lung Transplant. 2008; 27 (8): 898-904.
32. Hadjiliadis D, Davis RD, Palmer SM. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients? Chest. 2002; 122 (4): 1168-1175.
33. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report - 2010. J Heart Lung Transplant. 2010; 29 (10): 1104-1118.
34. Tashkin DP, Celli B, Senn S, et al UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359 (15): 1543- 1554.
35. Pepke-Zaba J, Gilbert C, Collings L, Brown MCJ. Sildenafil improves health-related quality of life in patients with pulmonary arterial hypertension. Chest. 2008; 133 (1): 183-189.
36. Zisman DA, Schwarz M, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW; Idiopathic Pulmonary Fibrosis Clinical Research Network. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med. 2010; 363 (7): 620-628.